CEACAM1 and metabolic dysfunction-associated steatotic liver disease: These findings suggest that a deeper understanding of CEACAM1 could reveal its importance in preventing hepatic insulin resistance associated with MASLD development and progression and could be a potential area of investigation for therapeutics targeting MASLD.